RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $11,745,000 | -0.4% | 543,990 | +1.5% | 0.12% | +3.5% |
Q2 2019 | $11,796,000 | -20.2% | 536,173 | -0.6% | 0.11% | -18.7% |
Q1 2019 | $14,785,000 | +6.8% | 539,391 | +4.8% | 0.14% | -4.1% |
Q4 2018 | $13,840,000 | -3.0% | 514,873 | +5.3% | 0.14% | +21.8% |
Q3 2018 | $14,262,000 | -8.7% | 488,943 | -2.1% | 0.12% | -16.8% |
Q2 2018 | $15,615,000 | +62.5% | 499,512 | +3.5% | 0.14% | +49.0% |
Q1 2018 | $9,607,000 | -28.8% | 482,764 | +4.0% | 0.10% | -29.9% |
Q4 2017 | $13,487,000 | – | 464,109 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |